I'm sorry that was a no brainer question the second part of which did not print through. I received the answer earlier today from an associate, but have a portion unanswered with respect to Pegasys/Ribivarin treatment for genotype 3a and the risk of further lung damage and/or breathing difficulties occurring as a result of treatment to someone with current COAD and since birth apnea (CPAP), who has family members with positive marfans, but does not have marfans, but may have beginnings of pneumothorax which shows as a small clear spot right thoracic xray, but is negative on non contrast ct. I understand if you do not wish to answer this as it was not part of the original question. Thank you.